Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2018-03, Vol.29 (3), p.766-771
Hauptverfasser: Gaspar, N., Marshall, L.V., Binner, D., Herold, R., Rousseau, R., Blanc, P., Capdeville, R., Carleer, J., Copland, C., Kerloeguen, Y., Norga, K., Pacaud, L., Sevaux, M.-A., Spadoni, C., Sterba, J., Ligas, F., Taube, T., Uttenreuther-Fischer, M., Chioato, S., O'Connell, M.A., Geoerger, B., Blay, J.-Y., Soria, J.C., Kaye, S., Wulff, B., Brugières, L., Vassal, G., Pearson, A.D.J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 771
container_issue 3
container_start_page 766
container_title Annals of oncology
container_volume 29
creator Gaspar, N.
Marshall, L.V.
Binner, D.
Herold, R.
Rousseau, R.
Blanc, P.
Capdeville, R.
Carleer, J.
Copland, C.
Kerloeguen, Y.
Norga, K.
Pacaud, L.
Sevaux, M.-A.
Spadoni, C.
Sterba, J.
Ligas, F.
Taube, T.
Uttenreuther-Fischer, M.
Chioato, S.
O'Connell, M.A.
Geoerger, B.
Blay, J.-Y.
Soria, J.C.
Kaye, S.
Wulff, B.
Brugières, L.
Vassal, G.
Pearson, A.D.J.
description
doi_str_mv 10.1093/annonc/mdy002
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5889024</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/annonc/mdy002</oup_id><els_id>S0923753419355140</els_id><sourcerecordid>1989598713</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-c51bfead716980a26a4f27ea5569033f9d5944a562af266bedc277c1ab974ac83</originalsourceid><addsrcrecordid>eNqFks9u1DAQxiMEokvhyBX5SA-htvPXHJBWq4WCVkJC5WzNOpPG4MTBdrbaW98B3oK36pPgJaUUJMTFlma--Y3mm0mSp4y-YFRkpzAMdlCnfbOnlN9LFqwoRVrTnN1PFlTwLK2KLD9KHnn_iVJaCi4eJkdcZAUrKrpIvr-zeggEGmvQKxzC9dVXaCYTCIIzezJ24JEoowetwJDgNBhPgiW6H53dIQGl0P-MDHhJGjddeNJad4foyaUOHVEwKHQvSSwbrT9QWmd7EjokfeynUx_gM3bWNOjIaCBESn999W25Wq036w_L8_Xj5EEb6_DJzX-cfHy9Pl-dpZv3b96ulptUFZSH-LJti9BUrBQ1BV5C3vIKoYjO0CxrRVOIPIei5NDystxio3hVKQZbUeWg6uw4eTVzx2nbx2ycwYGRo9M9uL20oOWfmUF38sLuZFHXgvI8Ak5mQPdX2dlyIw8xmkf7hah2LGqf3zRz9suEPsheR9uMgQHt5CUTtShEXbEsStNZqpz13mF7y2ZUHo5Bzscg52OI-md357hV_9r-7952Gv_LqmYpRuN3Gp30SmPcaKMdqiAbq_9R-QPsqdpO</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1989598713</pqid></control><display><type>article</type><title>Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Gaspar, N. ; Marshall, L.V. ; Binner, D. ; Herold, R. ; Rousseau, R. ; Blanc, P. ; Capdeville, R. ; Carleer, J. ; Copland, C. ; Kerloeguen, Y. ; Norga, K. ; Pacaud, L. ; Sevaux, M.-A. ; Spadoni, C. ; Sterba, J. ; Ligas, F. ; Taube, T. ; Uttenreuther-Fischer, M. ; Chioato, S. ; O'Connell, M.A. ; Geoerger, B. ; Blay, J.-Y. ; Soria, J.C. ; Kaye, S. ; Wulff, B. ; Brugières, L. ; Vassal, G. ; Pearson, A.D.J.</creator><creatorcontrib>Gaspar, N. ; Marshall, L.V. ; Binner, D. ; Herold, R. ; Rousseau, R. ; Blanc, P. ; Capdeville, R. ; Carleer, J. ; Copland, C. ; Kerloeguen, Y. ; Norga, K. ; Pacaud, L. ; Sevaux, M.-A. ; Spadoni, C. ; Sterba, J. ; Ligas, F. ; Taube, T. ; Uttenreuther-Fischer, M. ; Chioato, S. ; O'Connell, M.A. ; Geoerger, B. ; Blay, J.-Y. ; Soria, J.C. ; Kaye, S. ; Wulff, B. ; Brugières, L. ; Vassal, G. ; Pearson, A.D.J. ; Members of Working Group 1 of the Paediatric Platform of ACCELERATE</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy002</identifier><identifier>PMID: 29351570</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Antineoplastic Agents - therapeutic use ; Clinical Trials as Topic ; Drug Development ; Female ; Humans ; Industry Corner: s and Controversies ; Life Sciences ; Male ; Neoplasms - drug therapy ; Young Adult</subject><ispartof>Annals of oncology, 2018-03, Vol.29 (3), p.766-771</ispartof><rights>2018 THE AUTHORS</rights><rights>The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2018</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-c51bfead716980a26a4f27ea5569033f9d5944a562af266bedc277c1ab974ac83</citedby><cites>FETCH-LOGICAL-c502t-c51bfead716980a26a4f27ea5569033f9d5944a562af266bedc277c1ab974ac83</cites><orcidid>0000-0001-7190-120X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29351570$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04515997$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Gaspar, N.</creatorcontrib><creatorcontrib>Marshall, L.V.</creatorcontrib><creatorcontrib>Binner, D.</creatorcontrib><creatorcontrib>Herold, R.</creatorcontrib><creatorcontrib>Rousseau, R.</creatorcontrib><creatorcontrib>Blanc, P.</creatorcontrib><creatorcontrib>Capdeville, R.</creatorcontrib><creatorcontrib>Carleer, J.</creatorcontrib><creatorcontrib>Copland, C.</creatorcontrib><creatorcontrib>Kerloeguen, Y.</creatorcontrib><creatorcontrib>Norga, K.</creatorcontrib><creatorcontrib>Pacaud, L.</creatorcontrib><creatorcontrib>Sevaux, M.-A.</creatorcontrib><creatorcontrib>Spadoni, C.</creatorcontrib><creatorcontrib>Sterba, J.</creatorcontrib><creatorcontrib>Ligas, F.</creatorcontrib><creatorcontrib>Taube, T.</creatorcontrib><creatorcontrib>Uttenreuther-Fischer, M.</creatorcontrib><creatorcontrib>Chioato, S.</creatorcontrib><creatorcontrib>O'Connell, M.A.</creatorcontrib><creatorcontrib>Geoerger, B.</creatorcontrib><creatorcontrib>Blay, J.-Y.</creatorcontrib><creatorcontrib>Soria, J.C.</creatorcontrib><creatorcontrib>Kaye, S.</creatorcontrib><creatorcontrib>Wulff, B.</creatorcontrib><creatorcontrib>Brugières, L.</creatorcontrib><creatorcontrib>Vassal, G.</creatorcontrib><creatorcontrib>Pearson, A.D.J.</creatorcontrib><creatorcontrib>Members of Working Group 1 of the Paediatric Platform of ACCELERATE</creatorcontrib><title>Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><subject>Adolescent</subject><subject>Adult</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Clinical Trials as Topic</subject><subject>Drug Development</subject><subject>Female</subject><subject>Humans</subject><subject>Industry Corner: s and Controversies</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Neoplasms - drug therapy</subject><subject>Young Adult</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><recordid>eNqFks9u1DAQxiMEokvhyBX5SA-htvPXHJBWq4WCVkJC5WzNOpPG4MTBdrbaW98B3oK36pPgJaUUJMTFlma--Y3mm0mSp4y-YFRkpzAMdlCnfbOnlN9LFqwoRVrTnN1PFlTwLK2KLD9KHnn_iVJaCi4eJkdcZAUrKrpIvr-zeggEGmvQKxzC9dVXaCYTCIIzezJ24JEoowetwJDgNBhPgiW6H53dIQGl0P-MDHhJGjddeNJad4foyaUOHVEwKHQvSSwbrT9QWmd7EjokfeynUx_gM3bWNOjIaCBESn999W25Wq036w_L8_Xj5EEb6_DJzX-cfHy9Pl-dpZv3b96ulptUFZSH-LJti9BUrBQ1BV5C3vIKoYjO0CxrRVOIPIei5NDystxio3hVKQZbUeWg6uw4eTVzx2nbx2ycwYGRo9M9uL20oOWfmUF38sLuZFHXgvI8Ak5mQPdX2dlyIw8xmkf7hah2LGqf3zRz9suEPsheR9uMgQHt5CUTtShEXbEsStNZqpz13mF7y2ZUHo5Bzscg52OI-md357hV_9r-7952Gv_LqmYpRuN3Gp30SmPcaKMdqiAbq_9R-QPsqdpO</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Gaspar, N.</creator><creator>Marshall, L.V.</creator><creator>Binner, D.</creator><creator>Herold, R.</creator><creator>Rousseau, R.</creator><creator>Blanc, P.</creator><creator>Capdeville, R.</creator><creator>Carleer, J.</creator><creator>Copland, C.</creator><creator>Kerloeguen, Y.</creator><creator>Norga, K.</creator><creator>Pacaud, L.</creator><creator>Sevaux, M.-A.</creator><creator>Spadoni, C.</creator><creator>Sterba, J.</creator><creator>Ligas, F.</creator><creator>Taube, T.</creator><creator>Uttenreuther-Fischer, M.</creator><creator>Chioato, S.</creator><creator>O'Connell, M.A.</creator><creator>Geoerger, B.</creator><creator>Blay, J.-Y.</creator><creator>Soria, J.C.</creator><creator>Kaye, S.</creator><creator>Wulff, B.</creator><creator>Brugières, L.</creator><creator>Vassal, G.</creator><creator>Pearson, A.D.J.</creator><general>Elsevier Ltd</general><general>Oxford University Press</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7190-120X</orcidid></search><sort><creationdate>20180301</creationdate><title>Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE</title><author>Gaspar, N. ; Marshall, L.V. ; Binner, D. ; Herold, R. ; Rousseau, R. ; Blanc, P. ; Capdeville, R. ; Carleer, J. ; Copland, C. ; Kerloeguen, Y. ; Norga, K. ; Pacaud, L. ; Sevaux, M.-A. ; Spadoni, C. ; Sterba, J. ; Ligas, F. ; Taube, T. ; Uttenreuther-Fischer, M. ; Chioato, S. ; O'Connell, M.A. ; Geoerger, B. ; Blay, J.-Y. ; Soria, J.C. ; Kaye, S. ; Wulff, B. ; Brugières, L. ; Vassal, G. ; Pearson, A.D.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-c51bfead716980a26a4f27ea5569033f9d5944a562af266bedc277c1ab974ac83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Clinical Trials as Topic</topic><topic>Drug Development</topic><topic>Female</topic><topic>Humans</topic><topic>Industry Corner: s and Controversies</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Neoplasms - drug therapy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gaspar, N.</creatorcontrib><creatorcontrib>Marshall, L.V.</creatorcontrib><creatorcontrib>Binner, D.</creatorcontrib><creatorcontrib>Herold, R.</creatorcontrib><creatorcontrib>Rousseau, R.</creatorcontrib><creatorcontrib>Blanc, P.</creatorcontrib><creatorcontrib>Capdeville, R.</creatorcontrib><creatorcontrib>Carleer, J.</creatorcontrib><creatorcontrib>Copland, C.</creatorcontrib><creatorcontrib>Kerloeguen, Y.</creatorcontrib><creatorcontrib>Norga, K.</creatorcontrib><creatorcontrib>Pacaud, L.</creatorcontrib><creatorcontrib>Sevaux, M.-A.</creatorcontrib><creatorcontrib>Spadoni, C.</creatorcontrib><creatorcontrib>Sterba, J.</creatorcontrib><creatorcontrib>Ligas, F.</creatorcontrib><creatorcontrib>Taube, T.</creatorcontrib><creatorcontrib>Uttenreuther-Fischer, M.</creatorcontrib><creatorcontrib>Chioato, S.</creatorcontrib><creatorcontrib>O'Connell, M.A.</creatorcontrib><creatorcontrib>Geoerger, B.</creatorcontrib><creatorcontrib>Blay, J.-Y.</creatorcontrib><creatorcontrib>Soria, J.C.</creatorcontrib><creatorcontrib>Kaye, S.</creatorcontrib><creatorcontrib>Wulff, B.</creatorcontrib><creatorcontrib>Brugières, L.</creatorcontrib><creatorcontrib>Vassal, G.</creatorcontrib><creatorcontrib>Pearson, A.D.J.</creatorcontrib><creatorcontrib>Members of Working Group 1 of the Paediatric Platform of ACCELERATE</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Oxford Journals Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gaspar, N.</au><au>Marshall, L.V.</au><au>Binner, D.</au><au>Herold, R.</au><au>Rousseau, R.</au><au>Blanc, P.</au><au>Capdeville, R.</au><au>Carleer, J.</au><au>Copland, C.</au><au>Kerloeguen, Y.</au><au>Norga, K.</au><au>Pacaud, L.</au><au>Sevaux, M.-A.</au><au>Spadoni, C.</au><au>Sterba, J.</au><au>Ligas, F.</au><au>Taube, T.</au><au>Uttenreuther-Fischer, M.</au><au>Chioato, S.</au><au>O'Connell, M.A.</au><au>Geoerger, B.</au><au>Blay, J.-Y.</au><au>Soria, J.C.</au><au>Kaye, S.</au><au>Wulff, B.</au><au>Brugières, L.</au><au>Vassal, G.</au><au>Pearson, A.D.J.</au><aucorp>Members of Working Group 1 of the Paediatric Platform of ACCELERATE</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>29</volume><issue>3</issue><spage>766</spage><epage>771</epage><pages>766-771</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29351570</pmid><doi>10.1093/annonc/mdy002</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-7190-120X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2018-03, Vol.29 (3), p.766-771
issn 0923-7534
1569-8041
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5889024
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adolescent
Adult
Antineoplastic Agents - therapeutic use
Clinical Trials as Topic
Drug Development
Female
Humans
Industry Corner: s and Controversies
Life Sciences
Male
Neoplasms - drug therapy
Young Adult
title Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T12%3A10%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Joint%20adolescent%E2%80%93adult%20early%20phase%20clinical%20trials%20to%20improve%20access%20to%20new%20drugs%20for%20adolescents%20with%20cancer:%20proposals%20from%20the%20multi-stakeholder%20platform%E2%80%94ACCELERATE&rft.jtitle=Annals%20of%20oncology&rft.au=Gaspar,%20N.&rft.aucorp=Members%20of%20Working%20Group%201%20of%20the%20Paediatric%20Platform%20of%20ACCELERATE&rft.date=2018-03-01&rft.volume=29&rft.issue=3&rft.spage=766&rft.epage=771&rft.pages=766-771&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy002&rft_dat=%3Cproquest_pubme%3E1989598713%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1989598713&rft_id=info:pmid/29351570&rft_oup_id=10.1093/annonc/mdy002&rft_els_id=S0923753419355140&rfr_iscdi=true